Vertex Pharmaceuticals Inc
BMV:VRTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
BMV:VRTX
|
US |
|
K
|
KDDI Corp
XMUN:DIP
|
JP |
|
P
|
Paychex Inc
DUS:PCX
|
US |
|
M
|
MetLife Inc
XMUN:MWZ
|
US |
|
A
|
Antofagasta PLC
XMUN:FG1
|
UK |
|
F
|
Fresnillo PLC
SWB:FNL
|
MX |
|
A
|
Autodesk Inc
XMUN:AUD
|
US |
|
Barsele Minerals Corp
XTSX:BME
|
CA |
|
A
|
Aeroports de Paris SA
XMUN:W7L
|
FR |
|
A
|
Adevinta ASA
SWB:AD5B
|
NO |
|
A
|
Ameriprise Financial Inc
SWB:A4S
|
US |
|
S
|
SSR Mining Inc
TSX:SSRM
|
CA |
|
C
|
Coca Cola HBC AG
ATHEX:EEE
|
CH |
|
F
|
First Citizens BancShares Inc (Delaware)
F:FC6A
|
US |
|
D
|
Datang International Power Generation Co Ltd
SWB:BJI
|
CN |
|
C
|
Chemours Co
SWB:2CU
|
US |
|
Majestic Gold Corp
XTSX:MJS
|
CA |
|
SPS Commerce Inc
NASDAQ:SPSC
|
US |
|
Q
|
Qiagen NV
XMUN:QIA
|
NL |
|
B
|
BHP Group Ltd
XMUN:BHP
|
AU |
|
P
|
Paychex Inc
SWB:PCX
|
US |
|
L
|
Laboratory Corporation of America Holdings
DUS:LAB
|
US |
|
H
|
Humana Inc
SWB:HUM
|
US |
|
S
|
Salesforce Inc
F:FOO
|
US |
Wall St Price Targets
VRTX Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VRTX is 9 841.89 MXN with a low forecast of 5 872.28 MXN and a high forecast of 11 858.2 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VRTX's stock price target?
Price Target
9 841.89
MXN
According to Wall Street analysts, the average 1-year price target for VRTX is 9 841.89 MXN with a low forecast of 5 872.28 MXN and a high forecast of 11 858.2 MXN.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 8 years is 15%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Net Income has been 42%. The projected CAGR for the next 8 years is 15%.
